For: | Almeida NS, Rocha R, de Souza CA, da Cruz ACS, Ribeiro BDR, Vieira LV, Daltro C, Silva R, Sarno M, Cotrim HP. Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease. World J Hepatol 2022; 14(8): 1643-1651 [PMID: 36157861 DOI: 10.4254/wjh.v14.i8.1643] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i8/1643.htm |
Number | Citing Articles |
1 |
Gyu Bae Lee, Youn Huh, Sang Hyun Lee, Byoungduck Han, Yang-Hyun Kim, Do-Hoon Kim, Seon Mee Kim, Youn Seon Choi, Kyung Hwan Cho, Ga Eun Nam. Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study. World Journal of Gastroenterology 2023; 29(45): 5962-5973 doi: 10.3748/wjg.v29.i45.5962
Abstract(281) |
Core Tip(327) |
Full Article(HTML)(1626)
|
Full Article with Cover (PDF)-4474K(51)
|
Full Article (Word)-248K(25)
|
Audio-553K(6)
|
Peer-Review Report-261K(32)
|
Answering Reviewers-105K(34)
|
Supplementary Material-166K(36)
|
Full Article (PDF)-554K(138)
|
Full Article (XML)-161K(35)
|
Times Cited (4)
|
Total Visits (4076)
|
Open
|
2 |
Thais Pontello de Vries, Aline Marcos Pires, Kiara Gonçalves Dias Diniz, Anna Luiza Soares Chagas, Diego Alves Vieira, Adriana Maria Kakehasi, Vivian Marques Miguel Suen, Tatiana Bering, Enrico Antonio Colosimo, Gifone Aguiar Rocha, Kátia de Paula Farah, Luciana Diniz Silva. Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis C. Nutrition in Clinical Practice 2024; 39(3): 568 doi: 10.1002/ncp.11141
|
3 |
Suprabhat Giri, Prajna Anirvan, Sumaswi Angadi, Ankita Singh, Anurag Lavekar. Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease. World Journal of Gastrointestinal Pathophysiology 2024; 15(1): 91100 doi: 10.4291/wjgp.v15.i1.91100
|
4 |
Lidia Valencia-Muntalà, Carmen Gómez-Vaquero, Maribel Mora, Laura Berbel-Arcobé, Diego Benavent, Javier Narváez, Xavier Juanola, Joan M. Nolla. Evaluating sarcopenia prevalence and SARC-F effectiveness in elderly Spanish women with RA: a comparative study of EWGSOP criteria. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1392604
|
5 |
Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung. Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography. Journal of Cachexia, Sarcopenia and Muscle 2024; doi: 10.1002/jcsm.13543
|
6 |
Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease. International Journal of Molecular Sciences 2023; 24(8): 7517 doi: 10.3390/ijms24087517
|
7 |
Xiaoyan Li, Jie He, Qiuhua Sun. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis. Clinical Nutrition 2024; 43(9): 2005 doi: 10.1016/j.clnu.2024.07.006
|
8 |
Tingwan Du, Lian Xiang, Jingjing Zhang, Chunmei Yang, Wenxin Zhao, Jialu Li, Yong Zhou, Ling Ma. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1138078
|
9 |
Christine L. Freer, Elena S. George, Sze-Yen Tan, Gavin Abbott, David Scott, Robin M. Daly. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank. Calcified Tissue International 2024; 114(6): 592 doi: 10.1007/s00223-024-01212-5
|